Duloxetine - Pain (Neuropathic)
You are here : Home > Formulary Search > Duloxetine - Pain (Neuropathic)
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Guidelines (Local)
PAD Profile
ChemicalSubstance :
Duloxetine
Indication :
Pain (Neuropathic)
Group Name :
Keywords :
neuropathic pain, diabetic neuropathy, postherpetic neuralgia, PHN
Brand Names Include :
Cymbalta
Important Information :
Licensed only for diabetic peripheral neuropathic pain but also recommended as per NICE CG173 (off- label indication) as a treatment option in neuropathic pain.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2
Committee Recommendations (2)
Duloxetine 60mg once daily or amitriptyline are recommended as treatment options at step 1 of the local neuropathic pain guidelines..
Duloxetine is licensed only for diabetic peripheral neuropathic pain but is also recommended by NICE as a treatment option in neuropathic pain.
See guidelines below.
GENERIC Duloxetine has been considered by the PCN and has been assigned a GREEN traffic light status
NOTE - the branded product, Cymbalta, was considered BLACK at the PCN in May 2017.
NOTE - the branded product, Cymbalta, was considered BLACK at the PCN in May 2017.
Other Indications
Below are listed other indications that Duloxetine is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Pain (Neuropathic).